OTC Markets EXMKT - Delayed Quote USD

Instadose Pharma Corp. (INSD)

0.2500
+0.2489
+(22,627.20%)
At close: June 5 at 8:00:00 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
11/30/2021
11/30/2020
Total Revenue
0
0
0
Cost of Revenue
--
--
0
Gross Profit
--
--
0
Operating Expense
588.7143
588.7143
33.3658
Operating Income
-588.7143
-588.7143
-33.3658
Pretax Income
-588.7143
-588.7143
-33.3658
Net Income Common Stockholders
-588.7143
-588.7143
-33.3138
Diluted NI Available to Com Stockholders
-588.7143
-588.7143
-33.3138
Basic EPS
-0.01
--
-0.00
Diluted EPS
-0.01
--
-0.00
Basic Average Shares
75,000.3120
--
75,000
Diluted Average Shares
75,000.3120
--
75,000
Total Expenses
588.7143
588.7143
33.3658
Net Income from Continuing & Discontinued Operation
-588.7143
-588.7143
-33.3138
Normalized Income
-588.7143
-588.7143
-33.3138
EBIT
-588.7143
-588.7143
-33.3658
EBITDA
-588.7143
-588.7143
-33.3658
Reconciled Cost of Revenue
--
--
0
Net Income from Continuing Operation Net Minority Interest
-588.7143
-588.7143
-33.3138
Normalized EBITDA
-588.7143
-588.7143
-33.3658
Tax Rate for Calcs
0
0
0
Tax Effect of Unusual Items
0
0
0
11/30/2020 - 10/27/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

CPHI China Pharma Holdings, Inc.
1.6300
+2.52%
 
SXTC China SXT Pharmaceuticals, Inc.
1.8300
-10.29%
 
SHPH Shuttle Pharmaceuticals Holdings, Inc.
0.1328
-9.35%
 
UTHR United Therapeutics Corporation
283.35
-0.98%
 
TEVA Teva Pharmaceutical Industries Limited
16.99
-4.07%
 
RGC Regencell Bioscience Holdings Limited
595.10
-2.52%